Adicet Bio, Inc. (ACET)
4.57
-0.57
(-11.09%)
USD |
NASDAQ |
Oct 16, 16:00
4.60
+0.03
(+0.66%)
After-Hours: 20:00
Adicet Bio Net Income (Quarterly) : -21.36M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -21.36M |
| March 31, 2026 | -20.24M |
| December 31, 2025 | -30.52M |
| September 30, 2025 | -26.86M |
| June 30, 2025 | -31.22M |
| March 31, 2025 | -28.21M |
| December 31, 2024 | -28.73M |
| September 30, 2024 | -30.48M |
| June 30, 2024 | -29.90M |
| March 31, 2024 | -28.02M |
| December 31, 2023 | -29.49M |
| September 30, 2023 | -49.88M |
| June 30, 2023 | -32.40M |
| March 31, 2023 | -30.88M |
| December 31, 2022 | -29.88M |
| September 30, 2022 | -22.00M |
| June 30, 2022 | -22.54M |
| March 31, 2022 | 4.618M |
| Date | Value |
|---|---|
| December 31, 2021 | -15.81M |
| September 30, 2021 | -14.01M |
| June 30, 2021 | -10.85M |
| March 31, 2021 | -21.32M |
| December 31, 2020 | -8.958M |
| September 30, 2020 | -14.78M |
| June 30, 2020 | -8.455M |
| March 31, 2020 | -4.486M |
| December 31, 2019 | -6.578M |
| September 30, 2019 | -14.78M |
| June 30, 2019 | -18.33M |
| March 31, 2019 | -11.07M |
| December 31, 2018 | -5.757M |
| September 30, 2018 | -8.407M |
| June 30, 2018 | -13.59M |
| March 31, 2018 | -9.859M |
| December 31, 2017 | -23.05M |
| September 30, 2017 | -3.31M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 21.36M |
| EPS Diluted (Quarterly) | -1.988 |
| Enterprise Value | -62.55M |
| Earnings Yield | -252.4% |
| Normalized Earnings Yield | -252.36 |